Skip to main navigation Skip to search Skip to main content

CVS Health continues to outperform Novo Nordisk Class B by 77.5% in the past three months

Press/Media

PeriodMar 31 2025

Media coverage

4

Media coverage

  • TitleCVS Health continues to outperform Novo Nordisk Class B by 77.5% in the past three months
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date03/31/25
    PersonsShannon Lynch
  • TitleCVS Health continues to outperform Zoetis by 53.9% in the past three months
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date03/31/25
    PersonsShannon Lynch
  • TitleCVS Health continues to outperform Roche by 35.0% in the past three months
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date03/31/25
    PersonsShannon Lynch
  • TitleCVS Health continues to outperform Cencora by 32.0% in the past three months
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date03/31/25
    PersonsShannon Lynch